Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Pathology. 2019 Apr;51(3):240-245. doi: 10.1016/j.pathol.2018.11.009. Epub 2019 Feb 21.
Histological subtyping of non-small cell lung cancer (NSCLC) is of utmost importance for therapy stratification. Common immunohistochemical markers to identify squamous lineage are CK5/6, p40, and p63. Although p40 is considered the gold standard by current guidelines, the agreement of all three markers is an important aspect for tumours more difficult to classify. A total of 1244 NSCLC including 569 squamous cell carcinomas (SqCC) and 675 adenocarcinomas were assembled on a tissue microarray and stained with CK5/6, p40, p63, TTF-1, and Napsin-A. Sensitivity and specificity for squamous lineage markers as well as agreement of CK5/6, p40 and p63 were calculated. Sensitivity of CK5/6, p40, and p63 for SqCC was 93%, 94%, and 94% and specificity was 98%, 97%, and 84%, respectively. Positivity for two of these markers was found in at least in 90% of SqCC. Highest agreement was observed for p40 and p63 (Cohen's kappa 0.80). We report a similar sensitivity of CK5/6, p40, and p63, but a decreased specificity of p63 as compared to CK5/6 and p40 for the identification of squamous lineage. Our results support the use of either CK5/6 or p40 over p63 in the routine diagnostic setting.
非小细胞肺癌(NSCLC)的组织学分型对治疗分层至关重要。常用于鉴定鳞状细胞系的免疫组织化学标志物包括 CK5/6、p40 和 p63。尽管目前的指南认为 p40 是金标准,但所有三种标志物的一致性对于更难分类的肿瘤是一个重要方面。总共收集了 1244 例 NSCLC,包括 569 例鳞状细胞癌(SqCC)和 675 例腺癌,这些病例被组装在组织微阵列上,并使用 CK5/6、p40、p63、TTF-1 和 Napsin-A 进行染色。计算了鳞状细胞系标志物的敏感性和特异性,以及 CK5/6、p40 和 p63 的一致性。CK5/6、p40 和 p63 对 SqCC 的敏感性分别为 93%、94%和 94%,特异性分别为 98%、97%和 84%。这些标志物中的两种标志物的阳性率至少在 90%的 SqCC 中发现。p40 和 p63 的一致性最高(Cohen's kappa 0.80)。与 CK5/6 和 p40 相比,我们报告了 CK5/6、p40 和 p63 的相似敏感性,但 p63 的特异性降低,用于鉴定鳞状细胞系。我们的结果支持在常规诊断环境中使用 CK5/6 或 p40 替代 p63。